Hairstetics

Hairstetics is a medical device company established in Israel in 2010, focusing on the aesthetic treatment of alopecia, or hair loss. The company was founded by Dvir Keren and Boaz Shenhav, both of whom have extensive backgrounds in the medical industry. Keren, a serial entrepreneur in the medical device sector, has founded companies in aesthetic medicine, interventional cardiology, and surgery, and is an inventor on over 50 patents. This experience in developing and marketing medical devices has been pivotal to Hairstetics's direction. The company operates in the global alopecia treatment market, which was estimated at $11.8 billion in 2021. Hairstetics specifically targets a gap in the market by developing solutions for female androgenetic alopecia, as women have historically been underserved by traditional surgical hair transplantation methods.

The company's business model centers on the sale of its proprietary medical device and the accompanying consumables to trained physicians. Hairstetics has secured a total of $5.82 million in funding through various rounds, with investors including Peregrine Ventures, Pontifax Venture Capital, Maayan Ventures, and others. The company is in its initial sales phase, having obtained CE certification for the European market and ANVISA certification for Brazil. The procedure is positioned as a minimally invasive, in-office treatment that provides immediate results, differentiating it from surgical options that often involve long recovery times.

The core product is the Hairstetics™ Hair Implant Device, a class IIb medical device that facilitates a non-surgical hair restoration procedure. The technology utilizes pre-loaded sterile cartridges, each containing 12 synthetic hairs, which allows a physician to implant multiple fibers at once, significantly reducing procedure time to under an hour. The synthetic hairs are made from highly biocompatible materials like nitinol and nylon, commonly used in other medical implants, and are attached to a miniature anchoring system designed for secure fixation within the scalp. This third-generation implantation system was developed to overcome safety and efficacy issues of earlier technologies from the 1980s and 1990s. The implants are available in seven colors and various styles and lengths to match the patient's natural hair, offering an immediate aesthetic outcome without the need for a donor area, which is a significant advantage for many female patients.

Keywords: alopecia treatment, hair restoration device, medical aesthetics, non-surgical hair implantation, female hair loss solution, androgenetic alopecia, Dvir Keren, Peregrine Ventures, hair implant device, medical device, aesthetic medicine, hair loss treatment, synthetic hair implants, minimally invasive procedure, CE certified medical device, ANVISA certified, alopecia management, hair density solution, aesthetic dermatology, hair implantation technology